Company intelligence / Profile preview

Orhag Group

Stockholm, Sweden

Ownership: Private
Development stage: Other

Overview

Orhag Group is a Swedish private investment firm that specializes in the life sciences, biotechnology, and medical technology sectors. The firm provides strategic capital and industrial expertise to innovative healthcare companies, primarily in the Nordic region. Founded by Lars Orhag, a prominent figure in the Swedish biotech industry, the group is known for its long-term investment approach and active involvement in its portfolio companies. Notable historical and current investments include significant stakes in Hansa Biopharma and Bonesupport.

Industry: Investors

Partnerships

Hansa BiopharmaBonesupport

Beyond the preview

Go deeper on Orhag Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orhag Group.

Explore the full profile